News
Much of the public distrust stems from false information around messenger RNA (mRNA) vaccines for COVID-19, even though they ...
StockStory.org on MSN13h
Reflecting On Therapeutics Stocks’ Q1 Earnings: Moderna (NASDAQ:MRNA)As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...
11d
Medindia on MSNCould a Tiny RNA Tag Hold the Key to Autism and Schizophrenia?New insights into how molecular changes in neurons impact brain development and disorders like autism and schizophrenia.
How does a cell know when it’s been damaged? A molecular alarm, set off by mutated RNA and colliding ribosomes, signals ...
To build proteins, cells rely on a molecule called transfer RNA, or tRNA. tRNAs act like protein-building couriers, where they read the genetic instructions from messenger RNA, mRNA, and deliver the ...
The elephant vaccine closely resembles other mRNA vaccines made for humans. mRNA packed in lipid nanoparticles carries ...
Pioneer in RNA research who gave children with SMA a future Sabine Löwer Communications Boehringer Ingelheim St ...
8d
News-Medical.Net on MSNSmallest known protein-based enzyme HARP reveals dual role in tRNA processingTo build proteins, cells rely on a molecule called transfer RNA, or tRNA. tRNAs act like protein-building couriers, where ...
Professor Hirohide Saito and his research team have developed a new microRNA-responsive hybrid mRNA switch, enabling precise, ...
With Terrana Biosciences, Moderna founder Flagship can apply its RNA knowledge to agricultural use cases like pest and ...
The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.
Opinion
6don MSNOpinion
Institutions like OMRF have had almost unbroken bipartisan support as a national biomedical research policy. Breaking it would be irreversibly tragic.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results